Roche to Buy InterMune for $8.3 Billion

Roche Holding said it agreed to buy San Francisco-based biotech company InterMune Inc. for $8.3 billion in cash, the biggest acquisition in years for the Swiss pharmaceutical giant after a string of much smaller purchases.



from WSJ.com: US Business http://ift.tt/YR4KM1

via IFTTT